标普和纳斯达克内在价值 联系我们

111, Inc. YI NASDAQ

NASDAQ Global Market • Healthcare • Medical - Pharmaceuticals • CN • USD

SharesGrow Score
29/100
1/5 Pass
SharesGrow Intrinsic Value
$32.89
+383%

111, Inc. (YI) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

分析师预估 每股收益(EPS)为 $3.57 和 营收为 $2.12B (下一财年).

每股收益(EPS)历史表现: 2024: 实际 $-7.52 vs 预期 $3.57 (不及预期 -310.8%). 分析师准确度: 0%.

EPS 预测 — YI

0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual –$7.52 vs Est $3.57 ▼ 147.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.

营收预测 — YI

15%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual $14.401B vs Est $2.122B ▲ 85.3% off
Revenue Trend
Analysts expect stable revenue going forward.
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言